This inventor holds 6 USPTO granted patents and 2 published patent applications and 2 EPO patents. Top assignee: Aveo Pharmaceuticals, Inc.. Active years: 2009-2025.
Location History:
- Burlington, MA (US) (2009)
- Bedford, MA (US) (2018 - 2021)
Company Filing History:
Years Active: 2009-2025
Title: Alisa C Bell: Innovator in Monoclonal Antibodies
Introduction
Alisa C Bell is a prominent inventor based in Bedford, MA (US). She has made significant contributions to the field of biotechnology, particularly in the development of monoclonal antibodies. With a total of 6 patents to her name, her work focuses on innovative solutions for treating cell proliferative diseases.
Latest Patents
Among her latest patents are the Anti-Notch3 antibody and Anti-notch3 antibodies. These monoclonal antibodies are designed to bind and inhibit the activation of human Notch3. They hold potential for treating various cell proliferative diseases and disorders, including certain forms of cancer that are associated with the activation and/or overexpression of Notch3.
Career Highlights
Alisa C Bell is currently associated with Aveo Pharmaceuticals, Inc., where she continues to advance her research and development efforts. Her work has been instrumental in pushing the boundaries of therapeutic options available for patients suffering from serious health conditions.
Collaborations
Throughout her career, Alisa has collaborated with notable colleagues, including Heidi Okamura and William M Winston, Jr. These partnerships have fostered a collaborative environment that enhances innovation and research outcomes.
Conclusion
Alisa C Bell's contributions to the field of monoclonal antibodies exemplify her dedication to advancing medical science. Her innovative patents and collaborative efforts position her as a key figure in the fight against cancer and other proliferative diseases.